Repositorio Dspace

Impaired brain glucose metabolism and presynaptic dopaminergic functioning in a mouse model of schizophrenia

Mostrar el registro sencillo del ítem

dc.contributor.author Tomasella, Eugenia
dc.contributor.author Falasco, Germán
dc.contributor.author Urrutia, Leandro
dc.contributor.author Bechelli, Lucila
dc.contributor.author Padilla, Lucia
dc.contributor.author Gelman, Diego M.
dc.date.accessioned 2021-01-28T15:30:34Z
dc.date.available 2021-01-28T15:30:34Z
dc.date.issued 2020-03-17
dc.identifier.citation Tomasella, E., Falasco, G., Urrutia, L., Bechelli, L., Padilla, L., Gelman, D.M., 2020. Impaired brain glucose metabolism and presynaptic dopaminergic functioning in a mouse model of schizophrenia. EJNMMI Res 10, 39. https://doi.org/10.1186/s13550-020-00629-x en_US
dc.identifier.uri https://repositorio.fleni.org.ar/handle/123456789/350
dc.identifier.uri https://doi.org/10.1186/s13550-020-00629-x
dc.description.abstract Background: Schizophrenia is a disease diagnosed by visible signs and symptoms from late adolescence to early adulthood. The etiology of this disease remains unknown. An objective diagnostic approach is required. Here, we used a mouse model that shows schizophrenia-like phenotypes to study brain glucose metabolism and presynaptic dopaminergic functioning by positron emission tomography (PET) and immunohistochemistry. PET scannings were performed on mice after the administration of [18F]-FDG or [18F]-F-DOPA. Glucose metabolism was evaluated in basal conditions and after the induction of a hyperdopaminergic state. Results: Mutant animals show reduced glucose metabolism in prefrontal cortex, amygdala, and nucleus reuniens under the hyperdopaminergic state. They also show reduced [18F]-F-DOPA uptake in prefrontal cortex, substantia nigra reticulata, raphe nucleus, and ventral striatum but increased [18F]-F-DOPA uptake in dorsal striatum. Mutant animals also show reduced tyrosine hydroxylase expression on midbrain neurons. Conclusions: Dopamine D2 mutant animals show reduced glucose metabolism and impaired presynaptic dopaminergic functioning, in line with reports from human studies. This mouse line may be a valuable model of schizophrenia, useful to test novel tracers for PET scanning diagnostic. en_US
dc.language.iso eng en_US
dc.publisher Springer en_US
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri https://creativecommons.org/licenses/by/2.5/ar/
dc.subject Dopamine en_US
dc.subject Dopamina en_US
dc.subject Schizophrenia en_US
dc.subject Esquizofrenia en_US
dc.title Impaired brain glucose metabolism and presynaptic dopaminergic functioning in a mouse model of schizophrenia en_US
dc.type info:eu-repo/semantics/publishedVersion
dc.type info:eu-repo/semantics/article en_US
dc.relation.ispartofVOLUME 10
dc.relation.ispartofNUMBER 1
dc.relation.ispartofPAGINATION 39
dc.relation.ispartofCOUNTRY Alemania
dc.relation.ispartofCITY Berlín
dc.relation.ispartofTITLE EJNMMI research
dc.relation.ispartofISSN 2191-219X
dc.type.snrd info:ar-repo/semantics/artículo es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/openAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/openAccess

Buscar en DSpace


Listar

Mi cuenta

Estadísticas